These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 874958)

  • 21. [Antihymenolepidose activity of the compound MST-02].
    Mikhaĭlitsyn FS; Sevbo DP; Trusov SN; Gitsu GA; Malakhova AIu
    Med Parazitol (Mosk); 2010; (1):47-8. PubMed ID: 20361638
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of antihymenolepidose activity of the compound MST-04].
    Mikhaĭlitsyn FS; Trusov SN; Sevbo DP; Gitsu GA; Malakhova AIu
    Med Parazitol (Mosk); 2009; (3):40. PubMed ID: 19830915
    [No Abstract]   [Full Text] [Related]  

  • 23. Anticestode activity of 3,5-dibromo-2'-chlorosalicylanilide-4'-isothiocyanate--a preliminary report.
    Gupta S; Katiyar JC; Sen AB; Dubey SK; Singh H; Sharma S; Iyer RN
    J Helminthol; 1980 Dec; 54(4):271-3. PubMed ID: 7229321
    [No Abstract]   [Full Text] [Related]  

  • 24. [Problem of the rational approach to the treatment of hymenolepiasis].
    Zubitskaia MA; Nasyrova RM; Ziganshina NKh; Isaeva KhB; Vasil'eva NM
    Pediatriia; 1987; (8):93-4. PubMed ID: 3684442
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antihymenolepidose activity of the compound MCT-22: preparation and study].
    Mikhaĭlitsyn FS; Gitsu GA; Sevbo DP; Trusov SN; Bolotina LA
    Med Parazitol (Mosk); 2010; (3):37-8. PubMed ID: 20873184
    [No Abstract]   [Full Text] [Related]  

  • 26. [The technology for manufacturing antiparasitic preparations. 6. The development of a technology for producing the anthelmintic Azinox (praziquantel) and the evaluation of its toxic and anthelmintic properties].
    Mikhaĭlitsyn FS; Sergovskaia NL; Lebedeva MN; Astaf'ev BA; Gitsu GA; Baiandina DG; Uvarova NA; Lychko ND
    Med Parazitol (Mosk); 1996; (4):36-9. PubMed ID: 9026672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Preparation of MCT-13 and investigation of its activity against hymenolepidosis].
    Sevbo DP; Trusov SN; Malakhova AIu; Gitsu GA; Mikhaĭlitsyn FS
    Med Parazitol (Mosk); 2010; (2):45. PubMed ID: 20608186
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effectiveness and tolerable fractional doses of fenesal, dichlosal, and trichlosal in the treatment of patients with hymenolepiasis].
    Grinenko NV; Bereslavich TN; Vishnivetskaia MB; Zhelezova NI; Al'van
    Med Parazitol (Mosk); 1973; 42(2):163-7. PubMed ID: 4805411
    [No Abstract]   [Full Text] [Related]  

  • 29. [The compound MCT-21 and its antihymenolepidose activity].
    Mikhaĭlitsyn FS; Gitsu GA; Sevbo DP; Trusov SN; Bolotina LA
    Med Parazitol (Mosk); 2010; (4):54-5. PubMed ID: 21400712
    [No Abstract]   [Full Text] [Related]  

  • 30. [Duration of follow-up of patients with hymenolepiasis after dehelmintization].
    Besedina TK; Livshits PM
    Med Parazitol (Mosk); 1976; 45(6):738-9. PubMed ID: 139543
    [No Abstract]   [Full Text] [Related]  

  • 31. [The new effective anticestodian agent fluxane].
    Trusov SN; Mikhaĭlitsyn FS; Sevbo DP; Arkhipov IA; Koveshnikova EI
    Med Parazitol (Mosk); 2006; (2):22-4. PubMed ID: 16813243
    [No Abstract]   [Full Text] [Related]  

  • 32. [Results and prospects of the studies on the pathogenesis, clinical aspects, treatment and organization of control of hymenolepiasis].
    Astaf'ev BA
    Med Parazitol (Mosk); 1978; 47(2):65-72. PubMed ID: 148571
    [No Abstract]   [Full Text] [Related]  

  • 33. Susceptibility, chemotherapeutic reaction & immunological response of rat & mouse to Hymenolepis nana--a comparative study.
    Katiyar JC; Gupta S; Sen AB
    Indian J Exp Biol; 1983 Jul; 21(7):371-4. PubMed ID: 6667992
    [No Abstract]   [Full Text] [Related]  

  • 34. [Duration of follow-up of patients with hymenolepiasis after treatment].
    Astaf'ev BA; Karnaukhov VK; Tamarkina EM
    Med Parazitol (Mosk); 1976; 45(6):739-43. PubMed ID: 1024161
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis and anthelmintic activity of a series of pyrazino[2,1-a][2]benzazepine derivatives.
    Brewer MD; Burgess MN; Dorgan RJ; Elliott RL; Mamalis P; Manger BR; Webster RA
    J Med Chem; 1989 Sep; 32(9):2058-62. PubMed ID: 2769679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The anticestodal activity of preparations made from the breadfruit].
    Rasfon K
    Med Parazitol (Mosk); 1991; (5):49-52. PubMed ID: 1758366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-activity relationships of imidazo[4,5-f]quinoline partial structures and analogs. Discovery of pyrazolo[3,4-f]quinoline derivatives as potent immunostimulants.
    Moyer MP; Weber FH; Gross JL
    J Med Chem; 1992 Nov; 35(24):4595-601. PubMed ID: 1469690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of fractional doses of phenasal, trichlorophene, dichlosal, and trichlosal on the cysticercoids and young forms of Hymenolepis in albino mice].
    Grinenko NV; Kochetkov AA; Arutiunian GK; Gorbacheva VA; Bereslavi TN
    Med Parazitol (Mosk); 1976; 45(2):176-8. PubMed ID: 1024136
    [No Abstract]   [Full Text] [Related]  

  • 39. [The search for new antiparasitic agents. 11. The acute toxicity and anticestodal activity of the new anthelmintic Tizanox compared with Azinox].
    Mikhaĭlitsyn FS; Kovalenko FP; Sergovskaia NL; Lebedeva MN; Dzhabarova VI; Lychko ND; Naĭdenova AS
    Med Parazitol (Mosk); 1992; (2):32-4. PubMed ID: 1435534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of the effect of phenasal on different segments of cestode strobila].
    Dovzhenko VA; Rusak LV; Budanova IS; Kosheleva LI
    Med Parazitol (Mosk); 1976; 45(2):169-73. PubMed ID: 1024134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.